Risk: Low–Moderate
Confidence: 91%
Trend: ImprovingThis is a centralized dashboard for my personal medical information. It is designed for streamlined access to key health metrics without the requirement of logging into third-party applications, such as the Kaiser portal. A key objective of this page is to facilitate the harvesting and in-depth analysis of this data by artificial intelligence systems to generate advanced health insights. This approach is intended to deepen my understanding of my health conditions and help identify effective management strategies in a timely manner by leveraging the latest available technologies.
Risk: Low–Moderate
Confidence: 91%
Trend: ImprovingYour WBC is 1.88 x10(9)/L. 8 entered CBC markers are within the entered reference ranges. 2 markers require closer review. Interpret the pattern with your healthcare professional and use trends rather than a single result.
Current medications: Eliquis, Carvedilol, Atorvastatin
Possible explanations remain clinical possibilities, not diagnoses. Your healthcare team must interpret the complete picture.
Most entered CBC markers remain stable. Abnormal values should be reviewed as part of the full CBC pattern and compared with prior testing rather than interpreted alone.
This CBC marker should be interpreted with its reference range, related blood-count values, symptoms, medications, and historical trend.
If the two entered values continued in the same direction, the next value could remain near the current range.
WBC is 1.88 x10(9)/L on Jun 11, 2026, which is below the entered reference range of 4–10.5 x10(9)/L. Compared with Mar 3, 2026, it is lower by 0.5 x10(9)/L (21.0% decrease).
This interpretation is specific to the white blood cell count marker and is based only on the values entered in this widget.
A low WBC is called leukopenia. It may be associated with infections, medications, nutritional deficiencies, bone-marrow suppression, autoimmune conditions, or hypersplenism. The CBC differential helps show which white-cell type is reduced.
AI summaries are informational and are not medical advice. Review results with a qualified healthcare professional.
RBC is 4.8 x10(12)/L on Jun 11, 2026, which is within the entered reference range of 4–5.5 x10(12)/L. Compared with Mar 3, 2026, it is higher by 0.02 x10(12)/L (0.4% increase).
This interpretation is specific to the red blood cell count marker and is based only on the values entered in this widget.
The RBC count is within the entered range. Hemoglobin, hematocrit and MCV are still needed to evaluate oxygen-carrying capacity and red-cell size.
AI summaries are informational and are not medical advice. Review results with a qualified healthcare professional.
Hemoglobin is 13.5 gm/dL on Jun 11, 2026, which is within the entered reference range of 13–17 gm/dL. Compared with Mar 3, 2026, it is lower by 0.1 gm/dL (0.7% decrease).
This interpretation is specific to the hemoglobin marker and is based only on the values entered in this widget.
Hemoglobin is within the entered range, indicating that the measured oxygen-carrying protein is currently in range. Trend, symptoms and iron stores still matter.
AI summaries are informational and are not medical advice. Review results with a qualified healthcare professional.
Hematocrit is 40.9 % on Jun 11, 2026, which is within the entered reference range of 37–50 %. Compared with Mar 3, 2026, it is lower by 0.4 % (1.0% decrease).
This interpretation is specific to the hematocrit marker and is based only on the values entered in this widget.
Hematocrit is within the entered range. It should still be interpreted with hemoglobin, RBC count, hydration and the historical trend.
AI summaries are informational and are not medical advice. Review results with a qualified healthcare professional.
MCV is 85.2 fL on Jun 11, 2026, which is within the entered reference range of 80–100 fL. Compared with Mar 3, 2026, it is lower by 1.2 fL (1.4% decrease).
This interpretation is specific to the mean corpuscular volume marker and is based only on the values entered in this widget.
MCV is within the entered range, meaning average red-cell size is normal. Anemia can still be present with a normal MCV, so hemoglobin and other indices remain important.
AI summaries are informational and are not medical advice. Review results with a qualified healthcare professional.
MCH is 28.1 pg on Jun 11, 2026, which is within the entered reference range of 28–35 pg. Compared with Mar 3, 2026, it is lower by 0.4 pg (1.4% decrease).
This interpretation is specific to the mch marker and is based only on the values entered in this widget.
The value is within the entered laboratory range. A normal result should still be interpreted with symptoms, related tests and the trend.
AI summaries are informational and are not medical advice. Review results with a qualified healthcare professional.
MCHC is 33 gm/dL on Jun 11, 2026, which is within the entered reference range of 31–36.5 gm/dL. Compared with Mar 3, 2026, it is higher by 0.1 gm/dL (0.3% increase).
This interpretation is specific to the mchc marker and is based only on the values entered in this widget.
The value is within the entered laboratory range. A normal result should still be interpreted with symptoms, related tests and the trend.
AI summaries are informational and are not medical advice. Review results with a qualified healthcare professional.
RDV, CV is 13.9 % on Jun 11, 2026, which is within the entered reference range of 11–14.5 %. Compared with Mar 3, 2026, it is higher by 0.1 % (0.7% increase).
This interpretation is specific to the rdv, cv marker and is based only on the values entered in this widget.
The value is within the entered laboratory range. A normal result should still be interpreted with symptoms, related tests and the trend.
AI summaries are informational and are not medical advice. Review results with a qualified healthcare professional.
RDW, SD is 43.5 fL on Jun 11, 2026, which is within the entered reference range of 36–50 fL. Compared with Mar 3, 2026, it is lower by 0.1 fL (0.2% decrease).
This interpretation is specific to the rdw, sd marker and is based only on the values entered in this widget.
The value is within the entered laboratory range. A normal result should still be interpreted with symptoms, related tests and the trend.
AI summaries are informational and are not medical advice. Review results with a qualified healthcare professional.
Platelet Count is 30 x10(9)/L on Jun 11, 2026, which is below the entered reference range of 140–375 x10(9)/L. Compared with Mar 3, 2026, it is lower by 1 x10(9)/L (3.2% decrease).
This interpretation is specific to the platelet count marker and is based only on the values entered in this widget.
The value is below the entered laboratory range. The significance depends on what this marker measures, related results, symptoms, medications and the historical trend.
AI summaries are informational and are not medical advice. Review results with a qualified healthcare professional.
Compare manually entered historical results. Select a test below to view its trend.
Collection Date: Jun 11, 2026
| Patient Name ▲ | Date ▲ | Blood Pressure ▲ | SpO2 ▲ | Heart Rate ▲ | HbA1c ▲ | Month ▲ |
|---|---|---|---|---|---|---|
| Sasha R Kaiser Permanente | 2025-08-31 14:11 | 121/66 mmHg Normal: <120/80 mmHg | 99% Normal: 95% - 100% | 65 bpm Normal: 60-100 bpm | 5.8% Normal: <5.7% | August |
| Sasha R Kaiser Permanente | 2025-07-05 22:38 | 117/67 mmHg Normal: <120/80 mmHg | 100% Normal: 95% - 100% | 64 bpm Normal: 60-100 bpm | 0% Normal: <5.7% | July |
| Sasha R Kaiser Permanente | 2025-07-06 13:08 | 116/69 mmHg Normal: <120/80 mmHg | 98% Normal: 95% - 100% | 74 bpm Normal: 60-100 bpm | 0% Normal: <5.7% | July |
| Sasha R Kaiser Permanente | 2025-07-07 16:45 | 110/57 mmHg Normal: <120/80 mmHg | 98% Normal: 95% - 100% | 72 bpm Normal: 60-100 bpm | 0% Normal: <5.7% | July |
| Sasha R Kaiser Permanente | 2025-07-08 18:10 | 110/61 mmHg Normal: <120/80 mmHg | 99% Normal: 95% - 100% | 74 bpm Normal: 60-100 bpm | 0% Normal: <5.7% | July |
| Sasha R Kaiser Permanente | 2025-07-10 20:46 | 108/63 mmHg Normal: <120/80 mmHg | 99% Normal: 95% - 100% | 75 bpm Normal: 60-100 bpm | 0% Normal: <5.7% | July |
| Sasha R Kaiser Permanente | 2025-07-11 22:31 | 117/64 mmHg Normal: <120/80 mmHg | 97% Normal: 95% - 100% | 74 bpm Normal: 60-100 bpm | 0% Normal: <5.7% | July |
| Patient Name ▲ | Date ▲ | Total Chol ▲ | LDL ▲ | HDL ▲ | Triglycerides ▲ | Month ▲ |
|---|---|---|---|---|---|---|
| Sasha R Kaiser Permanente | 2026-06-12 07:07 | 111 mg/dL Normal value <=239 mg/dl | 51 mg/dL Normal value <=159 mg/dl | 51 mg/dL Normal value >=40 mg/dl | 47 mg/dL Normal value <=499 mg/dl | June |
| Sasha R Kaiser Permanente | 2025-03-29 10:17 | 94 mg/dL Normal value <=239 mg/dl | 33 mg/dL Normal value <=159 mg/dl | 50 mg/dL Normal value >=40 mg/dl | 57 mg/dL Normal value <=499 mg/dl | March |
| Sasha R Kaiser Permanente | 2024-02-29 12:11 | 128 mg/dL Normal value <=239 mg/dl | 70 mg/dL Normal value <=159 mg/dl | 38 mg/dL Normal value >=40 mg/dl | 101 mg/dL Normal value <=499 mg/dl | February |
| Sasha R Kaiser Permanente | 2023-06-01 10:58 | 85 mg/dL Normal value <=239 mg/dl | 31 mg/dL Normal value <=159 mg/dl | 41 mg/dL Normal value >=40 mg/dl | 64 mg/dL Normal value <=499 mg/dl | June |
| Sasha R Kaiser Permanente | 2023-02-27 11:40 | 69 mg/dL Normal value <=239 mg/dl | 25 mg/dL Normal value <=159 mg/dl | 24 mg/dL Normal value >=40 mg/dl | 102 mg/dL Normal value <=499 mg/dl | February |
| Sasha R Kaiser Permanente | 2023-02-19 04:36 | 104 mg/dL Normal value <=239 mg/dl | 24 mg/dL Normal value <=159 mg/dl | 50 mg/dL Normal value >=40 mg/dl | 148 mg/dL Normal value <=499 mg/dl | February |
U.S. adults (18+) diagnosed with liver disease. Latest official CDC/NCHS public estimate.
Source: CDC / NCHSEstimated people worldwide living with cirrhosis. Use as global context, not U.S.-only data.
Source: WHO / Global Burden estimatesDeaths from chronic liver disease and cirrhosis in the United States.
Source: CDC / NCHS FastStatsLiver transplants performed in the United States.
Source: UNOS / OPTNEstimated U.S. adult prevalence of MASLD / fatty liver disease.
Source: Younossi et al. / published estimatesShare of chronic liver disease deaths attributable to alcohol-related causes.
Source: CDC / NCHSPeople in the United States estimated to be living with chronic hepatitis B.
Source: CDCPeople in the United States estimated to be living with chronic hepatitis C.
Source: CDCNew liver and intrahepatic bile duct cancer cases diagnosed in the United States.
Source: American Cancer SocietyOrgan donors reported in the United States.
Source: UNOS / OPTNApproximate 5-year relative survival rate for localized liver cancer.
Source: SEER / NCILiver disease related studies currently listed or recruiting.
Source: ClinicalTrials.govDeath rate from chronic liver disease and cirrhosis per 100,000 population.
Source: CDC / NCHS FastStatsChronic liver disease and cirrhosis ranking among U.S. leading causes of death.
Source: CDC / NCHS